Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Metronidazole Attenuates the Intensity of Inflammation in Experimental Autoimmune Uveitis

P. Seidler Stangova, O. Dusek, A. Klimova, J. Heissigerova, T. Kucera, P. Svozilkova

. 2019 ; 65 (5-6) : 265-274.

Language English Country Czech Republic

Document type Journal Article

Grant support
NV17-31248A MZ0 CEP Register

Autoimmune uveitis is a serious sightthreatening disease that in many cases fails to respond to conventional immunosuppressive or biological therapy. Experimental models used in research allow more detailed study of pathogenesis of the autoimmune process and testing new therapeutic strategies. Recent results show that infection can trigger autoimmune diseases, and some commensal microorganisms are essential in causing disease activity. The aim of this work was to assess the effect of broadspectrum antibiotics - combination of metronidazole and ciprofloxacin or metronidazole alone - on the intensity of intraocular inflammation in experimental autoimmune uveitis (EAU). EAU was induced in mouse strain C57BL/6J by interphotoreceptor retinoid- binding protein in complete Freund's adjuvant and pertussis toxin. The grade of uveitis was assessed clinically and histologically in haematoxylin and eosin- stained tissues. Lymphocytes and macrophages were detected in cryosections using the immunoperoxidase method with antibodies. The therapy was commenced one week before EAU induction and continued throughout the experiment. In addition, metronidazole treatment was also started two weeks before EAU induction. Antibiotics significantly reduced the intensity of uveitis compared to the control group (P < 0.05). The effects of combination of ciprofloxacin and metronidazole and of metronidazole alone were similar when the therapy started one week before EAU induction (P < 0.05). Metronidazole commenced two weeks before EAU induction and throughout the experiment suppressed the intensity of EAU with even higher statistical significance (P < 0.0001). It can be assumed that the high protective effect of metronidazole on EAU intensity may be due not only to its antimicrobial effect, but also to its immunomodulatory activity.

Bibliography, etc.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc21023451
003      
CZ-PrNML
005      
20211104134130.0
007      
ta
008      
210927s2019 xr ad f 000 0|eng||
009      
AR
035    __
$a (PubMed)32362310
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Seidler Štangová, Petra $7 xx0130065 $u Department of Ophthalmology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
245    10
$a Metronidazole Attenuates the Intensity of Inflammation in Experimental Autoimmune Uveitis / $c P. Seidler Stangova, O. Dusek, A. Klimova, J. Heissigerova, T. Kucera, P. Svozilkova
504    __
$a Literatura
520    9_
$a Autoimmune uveitis is a serious sightthreatening disease that in many cases fails to respond to conventional immunosuppressive or biological therapy. Experimental models used in research allow more detailed study of pathogenesis of the autoimmune process and testing new therapeutic strategies. Recent results show that infection can trigger autoimmune diseases, and some commensal microorganisms are essential in causing disease activity. The aim of this work was to assess the effect of broadspectrum antibiotics - combination of metronidazole and ciprofloxacin or metronidazole alone - on the intensity of intraocular inflammation in experimental autoimmune uveitis (EAU). EAU was induced in mouse strain C57BL/6J by interphotoreceptor retinoid- binding protein in complete Freund's adjuvant and pertussis toxin. The grade of uveitis was assessed clinically and histologically in haematoxylin and eosin- stained tissues. Lymphocytes and macrophages were detected in cryosections using the immunoperoxidase method with antibodies. The therapy was commenced one week before EAU induction and continued throughout the experiment. In addition, metronidazole treatment was also started two weeks before EAU induction. Antibiotics significantly reduced the intensity of uveitis compared to the control group (P < 0.05). The effects of combination of ciprofloxacin and metronidazole and of metronidazole alone were similar when the therapy started one week before EAU induction (P < 0.05). Metronidazole commenced two weeks before EAU induction and throughout the experiment suppressed the intensity of EAU with even higher statistical significance (P < 0.0001). It can be assumed that the high protective effect of metronidazole on EAU intensity may be due not only to its antimicrobial effect, but also to its immunomodulatory activity.
650    _2
$a zvířata $7 D000818
650    _2
$a ciprofloxacin $x farmakologie $x terapeutické užití $7 D002939
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a zánět $x komplikace $x farmakoterapie $x patologie $7 D007249
650    _2
$a metronidazol $x farmakologie $x terapeutické užití $7 D008795
650    _2
$a myši inbrední C57BL $7 D008810
650    _2
$a stupeň závažnosti nemoci $7 D012720
650    _2
$a uveitida $x komplikace $x farmakoterapie $x patologie $7 D014605
655    _2
$a časopisecké články $7 D016428
700    1_
$a Dušek, Otakar $7 xx0255534 $u Department of Ophthalmology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Klímová, Aneta, $d 1978- $7 xx0101280 $u Department of Ophthalmology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Heissigerová, Jarmila, $d 1973- $7 hka2015862052 $u Department of Ophthalmology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Kučera, Tomáš $7 xx0086044 $u Institute of Histology and Embryology, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Svozílková, Petra $7 xx0106153 $u Department of Ophthalmology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
773    0_
$w MED00011004 $t Folia biologica $x 0015-5500 $g Roč. 65, č. 5-6 (2019), s. 265-274
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32362310 $y Pubmed
856    41
$u https://fb.cuni.cz/file/5913/fb2019a0028.pdf $y plný text volně přístupný
910    __
$a ABA008 $b A 970 $c 89 $y p $z 0
990    __
$a 20210927 $b ABA008
991    __
$a 20210930154124 $b ABA008
999    __
$a ok $b bmc $g 1718860 $s 1143942
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 65 $c 5-6 $d 265-274 $i 0015-5500 $m Folia biologica (Praha) $n Folia biol. (Praha) $x MED00011004
GRA    __
$a NV17-31248A $p MZ0
LZP    __
$b NLK118 $a Pubmed-20210927

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...